Table 4

Per protocol analysis of ultrasound examination
Tocotrienols group (n = 30) Changes at completion of the study
Baseline Negative Mild Moderate Severe
Mild (n = 22) 13/22 9/22 0/22 0/22
73.3% 59.1% 40.9% 0.0% 0.0%
Moderate (n = 6) 2/6 4/6 0/6 0/6
20.0% 33.3% 66.7% 0.0% 0.0%
Severe (n = 2) 0/2 1/2 0/2 1/2
6.7% 0.0% 50.0% 0.0% 50.0%
  TOTAL 15/30 14/30 0/30 1/30
50.0% 46.7% 0.0% 3.3%
Placebo group (n = 34) Changes at completion of the study
Baseline Negative Mild Moderate Severe
Mild (n = 27) 8/27 17/27 2/27 0/27
79.4% 29.6% 63.0 7.4% 0.0%
Moderate (n = 6) 0/6 5/6 1/6 0/6
17.6% 0.0% 83.3% 16.7% 0.0%
Severe (n = 1) 0/1 0/1 1/1 0/1
2.9% 0.0% 0.0% 100.0% 0.0%
  TOTAL 8/34 22/34 4/34 0/34
23.5% 64.7% 11.8% 0.0%
Tocotrienols vs Placebo Chi Sq= 4.851 P= 0.014

Details of the clinical evaluation of subjects at baseline and relative changes after 1 year of treatment.

[Helmert-Pearson’s Chi Square; Numbers’09, GraphPad].

Magosso et al.

Magosso et al. Nutrition Journal 2013 12:166   doi:10.1186/1475-2891-12-166

Open Data